Poster session at Obesity Week 2025 by Resalis Therapeutics
EXADEX-INNOV is excited to announce that Resalis Therapeutics will present preclinical translational data at Obesity Week 2025, including results obtained on our human adipose tissue models Novel Therapy: Targeting miR-22 for Energy Expenditure The poster showcases RES-010, a novel antisense oligonucleotide developed by Resalis Therapeutics to inhibit miR-22, an important post-transcriptional regulator of metabolic pathways in […]